Next Article in Journal
Green Aromatic Epoxidation with an Iron Porphyrin Catalyst for One-Pot Functionalization of Renewable Xylene, Quinoline, and Acridine
Next Article in Special Issue
The Potential of Ginkgo biloba as a Source of Biologically Active Compounds—A Review of the Recent Literature and Patents
Previous Article in Journal
Identification of Small Molecule Inhibitors of Human Cytomegalovirus pUL89 Endonuclease Using Integrated Computational Approaches
Previous Article in Special Issue
The Effect of the Plant Stabilisation Method on the Composition and Antioxidant Properties of Elderflower (Sambucus nigra L.) Extract
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 9
10.3390/molecules28093939
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Analysis and Profiling of Antioxidants and Anticancer Compounds from Tephrosia purpurea (L.) subsp. apollinea Family Fabaceae

by
Ahmed M. M. Youssef
1,*,
Doaa A. M. Maaty
2 and
Yousef M. Al-Saraireh
3
1
Department of Pharmacology, Faculty of Pharmacy, Mutah University, P.O. Box 7, Al-Karak 61710, Jordan
2
Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Girls Branch, Cairo 11754, Egypt
3
Department of Pharmacology, Faculty of Medicine, Mutah University, P.O. Box 7, Al-Karak 61710, Jordan
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(9), 3939; https://doi.org/10.3390/molecules28093939
Submission received: 5 April 2023 / Revised: 30 April 2023 / Accepted: 4 May 2023 / Published: 7 May 2023
(This article belongs to the Special Issue Natural Bioactive Compounds from Edible and Inedible Parts of Plants)
Browse Figures
Versions Notes

Abstract

:
Tephorosia purpurea subsp. apollinea was extracted with methanol and n-hexane to obtain sub-fractions. The chemical compounds identified with GC-MS and HPLC in T. purpurea subsp. apollinea extracts showed antioxidant and anticancer properties. The antioxidant and anticancer activities were investigated using DDPH and ABTS assays, and MTT assay, respectively. Stigmasta-5,24(28)-dien-3-ol, (3 β,24Z)-, 9,12,15-octadecatrienoic acid methyl ester, phytol, chlorogenic acid, and quercetin were the major chemical compounds detected in T. purpurea subsp. apollinea. These compounds possessed antioxidant and anticancer properties. The methanol extract showed antioxidant properties with DDPH and ABTS radical scavenging of 84% and 94%, respectively, relative to ascorbic acid and trolox. The anticancer effects of T. purpurea subsp. apollinea against the cancer cell lines MCF7 (IC50 = 102.8 ± 0.6 μg/mL), MG63 (IC50 = 118.3 ± 2.5 μg/mL), T47D (IC50 = 114.7 ± 1.0 μg/mL), HeLa (IC50 = 196.3 ± 2.3 μg/mL), and PC3 (IC50 = 117.7 ± 1.1 μg/mL) were greater than its anticancer effects against U379 (IC50 = 248.4 ± 7.5 μg/mL). However, it had no adverse effects on the normal cells (WI38) (IC50 = 242.9 ± 1.8 μg/mL). Therefore, the major active constituents presented in T. purpurea subsp. apollinea can be isolated and studied for their potential antioxidant and anticancer effects against breast, cervical, and prostate cancers and osteosarcoma.

Graphical Abstract

1. Introduction

Despite the advancements in different therapeutic strategies, cancer continues to be a foremost cause of mortality worldwide. Conventional cancer therapies include radiotherapy, chemotherapy, and surgery. However, serious side effects and drug resistance to these treatments decrease their effectiveness [1]. The development of such problems, particularly chemotherapy drug resistance, is considered one of the main contributors to cancer-related mortality. Different multiple mechanisms are employed by cancer cells to decrease the therapeutic benefits of anticancer drugs. These include, but are not limited to, alteration in expressions of targeted proteins, DNA repair mechanisms, drug detoxification, and inactivation of medication by several catalytic proteins [2,3,4]. Therefore, there is a need to identify novel drug targets, as well as use of unique sources of anticancer drugs such as natural products [5,6]. As anticancer agents, natural products constitute an acceptable therapeutic strategy due to their availability, applicability, and low cytotoxicity. Importantly, they may provide new therapeutic strategies for combating drug resistance seen with traditional chemotherapy via several mechanisms of action.
Numerous secondary metabolites with different chemical structural diversities and biological effects have demonstrated significant potential in the treatment of various carcinomas [7]. Overall, natural products have the potential to be promising sources of novel anticancer drugs, making them an essential field of research.
The imbalance between the generation of oxidants and the antioxidant defense mechanism in the human body is known as oxidative stress [8]. Oxidative stress may cause cardiovascular and respiratory diseases such as coronary heart disease, hypertension, and chronic obstructive pulmonary disease [8]. It also may produce neurodegeneration-associated ailments such as Alzheimer’s and Parkinson’s diseases [8]. Additionally, oxidative stress strongly contributes to cancer development and metastasis [8]. Oxygen- and nitrogen-derived free radicals are reactive entities that are involved in the induction of oxidative stress that causes cellular damage [9]. Antioxidants from natural products have been widely investigated for preventing oxidative stress [10] and for the treatment of different illnesses, e.g., inflammation, carcinoma, diabetes, and neurodegenerative diseases [11]. For example, it has been demonstrated that Portulaca oleracea extract produced potential protective effects against neuroinflammatory disease, memory loss, and oxidative stress induced by lipopolysaccharide in mice [12].
Tephrosia belongs to the family Fabaceae [13]. It is widespread in tropical and subtropical regions of the world [14]. It has been widely used in folk medicine [14]. Tephrosia purpurea (L.) is a member of genus Tephrosia [13]. It has two sub-species (subsp.), leptostachya (DC.) Brummitt and apollinea (Delile) Hosni and El-Karemy [13]. Both sub-species grow in Egypt [13]. The T. purpurea subsp. apollinea is distributed in the Nile Delta, Nile banks, and desert wadis, especially Wadi Allaqi (Nubia), Gebel Elba (southern Egypt), and Sudan [13]. Several studies have revealed that the flavonoids and phenolic components of the genus Tephrosia have potent pharmacological effects, including pesticidal, insecticidal, and anticancer properties, especially against the human breast cancer cell line MCF7 [15]. For example, rotenoids, terpenoids, sterols, essential oils, and fixed oils have been identified as chemical compounds in the Tephrosia species [16]. Moreover, the Tephrosia species contains a large amount of flavonoids with antioxidant and anticancer effects [16]. The objective of this study is to analyze the chemical compounds in solvent subfractions of T. purpurea subsp. apollinea, in addition to investigation of their antioxidant and anticancer effects, for the first time.

2. Results

2.1. Phytochemical Compounds

Many phytochemicals were present in the methanol extract of T. purpurea subsp. apollinea using GC-MS (Table 1 and Figure 1 and Figure 2). The results revealed the presence of several classes of compounds, such as steroids, triterpenoids, sesquiterpenoids, fatty acids, alkaloids, isoflavonoids, and miscellaneous compounds. The steroid stigmasta-5,24(28)-dien-3-ol,(3β,24Z)- relative abundance (RA = 44.74%) was the major compound in the methanol extract, followed by ethyl iso-allocholate (RA = 9.43%), a type of steroid derivative; however, androstan-17-one, 3-ethyl-3-hydroxy-, (5alpha)- (RA = 1.20%) is another steroid with small amount. The methanol extract of T. purpurea subsp. apollinea also contained two types of terpenoids, sesquiterpenoid β-caryophyllene (RA = 2.31%) and triterpenoids olean-12-en-28-oic acid (RA = 1.82%) (Figure 1 and Table 1). Fatty acid methyl esters 10-octadecenoic acid methyl ester (RA = 4.31%), palmitic acid methyl ester (RA = 4.06%), 9,12-octadecadienoic acid methyl ester (RA = 3.28%), oxiraneundecanoic acid, 3-pentyl-methyl ester, trans- (RA = 0.99%), and cholest-5-en-3-ol, 24-propylidene-, (3 alpha)- (RA = 0.65%) were found in the plant extract. Furthermore, the results revealed presence of the alkaloid pseudosolasodine diacetate (RA = 1.55%), aromatic organic compound benzene,1-methoxy-4-(1-propenyl)- (RA = 5.88%), alcoholic compound 1-heptatriacotanol (RA = 3.85%), isoflavonoid flavone 4′-OH,5-OH,7-di-O-glucoside (RA = 2.49%) and triglyceride 9-octadecenoic acid,1,2,3-propanetriyl ester (RA = 0.96%). The 3′,8,8′-Trimethoxy-3-piperidyl-2,2′-binaphthalene-1,1′,4,4′-tetrone (RA = 5.99%) is an identified oxygen organic compound and found in the methanolic extract. The carotene rhodopin (RA = 2.30%), the carboxylic ester glycidyl oleate (RA = 3.74%), and glycerol derivative 1,3-dielaidin (RA = 1.87%) were also found in the plant extract.
On the other hand, it was found through GC-MS analysis that the n-hexane extract of T. purpurea subsp. apollinea had 17 identified components (Table 2, Figure 3 and Figure 4). These detected components were classified into esters, hydrocarbons, diterpenes, steroids, fatty acid amide, phenols, and other organic compounds. The identified fatty acid methyl esters were 9,12,15-octadecatrienoic acid methyl ester, with relative abundance (RA) of 0.67%), hexadecanoic acid methyl ester (RA = 0.37%), methyl stearate (RA = 0.07%), and cis-5,8,11-eicosatrienoic acid methyl ester (RA = 0.08%), while the identified esters were pentafluoropropionic acid octadecyl ester (RA = 0.17%), 4-ethylbenzoic acid undec-2-enyl ester (RA = 0.05%), acetic acid, 10,11-dihydroxy-3,7,11-trimethyl-dodeca-2,6-dienyl ester (RA = 0.08%), and the identified phthalate ester was a bis(2-ethylhexyl) phthalate (RA = 0.35%). The identified acyclic diterpene was a phytol (RA = 0.61%). The plant extract also contained alkanes tetradecane (RA = 0.08%), pentadecane (RA = 0.20%), 2-methyltetracosane (RA = 0.18%), and the identified aliphatic hydrocarbon was heneicosane (RA = 0.60%). The plant extract contained long-chain alcohol 1-heptacosanol (RA = 0.43%), fatty acid amide palmitoleamide (RA = 0.13%), phenol 2,4-di-tert-butylphenol (RA = 0.08%), and steroid gamma-sitosterol (RA = 0.05%). Additionally, another organic compound found in the extract was tributyl acetylcitrate (RA = 0.04%).
Total phenolic content of aerial parts of T. purpurea subsp. apollinea was 39.12 mg GAE/g DWt, and total flavonoids amounted to 17.83 mg CE/g DWt. The content of phenolic compounds in methanolic extract of T. purpurea subsp. apollinea was determined with HPLC quantitative analysis, which led to the identification of flavonoids, flavones, flavonols, and other phenolics, as shown in Table 3 and Figure 5. The identified phenolic acids were gallic acid (1.24 mg/100 g DWt or mg%) and ferulic acid (0.14 mg/100 g DWt). Chlorogenic acid (8.10 mg/100 g DWt), pyrocatechol (0.36 mg/100 g DWt), and coumaric acid (0.15 mg/100 g DWt) were the identified phenolic compounds. The identified gallate ester was methyl gallate (0.44 mg/100 g DWt). Caffeic acid (0.66 mg/100 g DWt) was the detected polyphenol. Additionally, the phenolic aldehyde vanillin (0.45 mg/100 g DWt) was detected. The plant extract also contained the tannin ellagic acid (0.06 mg/100 g DWt) and the monocarboxylic acid cinnamate (0.01 mg/100 g DWt). Quercetin (6.76 mg/100 g DWt) and rutin (0.76 mg/100 g DWt) were the main identified flavonoids. The plant also contained the flavonol kaempferol (2.29 mg/100 g DWt), and flavanone naringenin (0.12 mg/100 g DWt), as well as hesperetin (0.06 mg/100 g DWt). The identified isoflavone was daidzein (0.07 mg/100 g DWt), while the identified flavone was apigenin (0.01 mg/100 g DWt).

2.2. Antioxidants Capacity

The antioxidant activity of T. purpurea subsp. apollinea methanolic extract was investigated using DPPH and ABTS radical scavenging assays (Table 4 and Table 5).
A curve was plotted showing the percentage of DPPH and ABTS radical scavenging activities vs. concentration, and the concentration of the sample required to scavenge 50% of DPPH and ABTS free radicals, which is known as IC50, was determined using GraphPad Prism 8 (Figure 6). The result of the DPPH assay showed that the methanol extract of T. purpurea subsp. apollinea had IC50 of 46.7 ± 0.7 μg/mL. However, ascorbic acid (a positive control) had IC50 of 4.8 ± 0.1 μg/mL. At a concentration of 1000 μg/mL of T. purpurea subsp. apollinea methanolic extract, the DPPH scavenging percentage was 84.17% (Table 4). Additionally, data from ABTS studies were comparable to the results of DPPH radical assay, and the antioxidant effect of T. purpurea subsp. apollinea methanolic extract had IC50 of 46.7 ± 2.6 μg/mL. However, trolox (a positive control) had IC50 of 2.9 ± 0.1 μg/mL. At a concentration of 150 μg/mL of T. purpurea subsp. apollinea methanolic extract, the ABTS scavenging percentage was 94.56% (Table 5). This may indicate potential antioxidant properties of T. purpurea subsp. apollinea.

2.3. Antitumor Capacity

The half-maximal inhibitory concentration (IC50) was determined by plotting the logarithmic concentration of T. purpurea subsp. apollinea extract on the X-axis, and % cytotoxicity on the Y-axis. For example, T. purpurea subsp. apollinea showed IC50 of 102.85 ± 0.58 μg/mL against MCF-7, while doxorubicin, a positive control, showed IC50 of 7.43 ± 0.11 μg/mL (Figure 7).
The MTT assay was performed to investigate the antitumor activity of T. purpurea subsp. apollinea extract against breast cancer (MCF7), osteosarcoma (MG63), breast ductal carcinoma (T47D), cervical cancer (HeLa), prostate cancer (PC3), and leukemia (U937). Values of IC50 for T. purpurea subsp. apollinea extract were compared to that of doxorubicin using t-test analysis. Based on NCI criteria, the methanol extract of T. purpurea subsp. apollinea showed variable toxic effects (Figure 8, Figure 9 and Figure 10). The IC50 values for activities of T. purpurea subsp. apollinea against breast cancer (MCF7) (102.8 ± 0.5 μg/mL), osteosarcoma (MG63) (118.3 ± 2.4 μg/mL), breast ductal carcinoma (T47D) (114.7 ± 1.0 μg/mL), cervical cancer (HeLa) (196.2 ± 2.3 μg/mL), and prostate cancer (PC3) (117.6 ± 1.0 μg/mL) were mild, relative to standard drug (Table 6). In contrast, the extract activity against leukemia (U937) (248.4 ± 7.5 μg/mL) was feeble in comparison with doxorubicin. Additionally, the normal human fetal lung fibroblast (WI38) (242.9 ± 1.8 μg/mL) was weakly influenced by the cytotoxicity of T. purpurea subsp. apollinea extract, relative to doxorubicin. The SI values of T. purpurea subsp. apollinea methanol extract were calculated as indicated above. As a result, no cytotoxic selectivity for T. purpurea subsp. apollinea extract was observed, as presented in Table 7. Cells exposed to T. purpurea subsp. apollinea methanolic extract (0.2 mg/mL) for 3 days were microscopically investigated. The cell lines MCF7, MG63, T47D, HeLa, and PC3 were rounded and shrunk by the methanolic extract of T. purpurea subsp. apollinea. However, WI38 cell lines demonstrated small changes in morphology when treated with T. purpurea subsp. apollinea, compared to their control cell lines (Figure 8 and Figure 9). The U937 cell lines could not be microscopically examined.

3. Discussion

The methanolic extract of T. purpurea subsp. apollinea was analyzed using GC-MS, and the identified compounds were shown to possess antioxidant and anticancer properties. These compounds were responsible for the antioxidant and anticancer effects of T. purpurea subsp. apollinea on most of the tested cancer cell lines. The identified sesquiterpenoid that has been associated with antioxidant and anticancer properties was β-caryophyllene [17]. The palmitic acid methyl ester [18,19], 9,12-octadecadienoic acid methyl ester [22], 10-octadecenoic acid methyl ester [23], and oxiraneundecanoic acid 3-pentyl- methyl ester, trans [24] are fatty acid methyl esters that exert antioxidant and anticancer effects. Pseudosolasodine diacetate has been reported as an alkaloid compound with antioxidant properties [20]. Additionally, the identified steroid was ethyl iso-allocholate which has been reported to possess antioxidant properties [25]. The other identified steroid, stigmasta-5,24(28)-dien-3-ol, (3β,24Z), which was present at the highest level among the compounds in the plant, has been reported as an antioxidant [28]. Androstan-17-one, 3-ethyl-3-hydroxy-,(5alpha) is also an identified steroid with antioxidant properties [21]. The detected isoflavonoid was a flavone 4’-OH,5-OH,7-di-O-glucoside with antioxidant and anticancer properties [29,30]. Additionally, 1-heptatriacotanol is an identified alcoholic compound and is reported to have anticancer properties [32]. The oxygen organic compound 3’,8,8’-trimethoxy-3-piperidyl-2,2’-binaphthalene-1,1’,4,4’-tetrone has been reported with antioxidant and antibacterial properties [26]. Rhodopin is an identified carotene and has been reported to have antioxidant properties [31]. The carboxylic ester which has been reported with anticancer properties is glycidyl oleate [33]. Other identified compounds have not been evaluated for either antioxidant or anticancer properties. However, they have been reported with other biological activities. These are the fatty acid cholest-5-en-3-ol, 24-propylidene-(3 alpha) [27], and the triglyceride 9-octadecenoic acid, 1,2,3-propanetriyl ester [34,35] that have been reported with antibacterial and inflammation suppressing effects, respectively. However, the biological properties of the identified triterpenoid olean-12-en-28-oic acid, the aromatic organic compound benzene,1-methoxy-4-(1-propenyl), and glycerol derivative 1,3-dielaidin have not been evaluated until now.
The identification of the compounds of n-hexane subfraction extract of T. purpurea subsp. apollinea was performed with GC-MS. The majority of compounds in n-hexane subfraction extract possess antioxidant and anticancer properties. The identified phenol with antioxidant activity was 2,4-di-tert-butylphenol [37]. Additionally, hexadecanoic acid methyl ester [39], 9,12,15-octadecatrienoic acid methyl ester, which was present at the highest level relative to the other constituents [42], and methyl stearate [45] were the identified fatty acids methyl esters that are known to exert antioxidant and anticancer effects. However, the fatty acid methyl ester cis-5,8,11-eicosatrienoic acid methyl ester exerts anti-inflammation-related effects [48]. The identified diterpene was phytol, of which there was a considerable amount relative to the other components, and it has antioxidative stress and anticancer activities [43,44]. The long-chain alcohol 1-heptacosanol has been reported to be an antioxidant [46]. The identified fatty acid amide with antioxidant properties was palmitoleamide [50]. Bis(2-ethylhexyl) phthalate exerts antioxidant and antitumor effects [52]. Additionally, gamma-sitosterol is a steroid that has been reported to possess anticancer activity [54]. The other identified compounds have not been evaluated for either antioxidant or anticancer properties; however, they have been evaluated for different biological activities. For example, pentadecane [38], tetradecane [36], and 2-methyltetracosane [49] are alkanes with antibacterial effects. An aliphatic hydrocarbon (heneicosane) [41] and carbonyl compound (tributyl acetylcitrate) [47] have been reported to possess pesticidal and antimicrobial activities, respectively, while acetic acid, 10,11-dihydroxy-3,7,11-trimethyl-dodeca-2,6-dienyl ester [51] and pentafluoropropionic acid octadecyl ester [40] are the identified esters and have been reported with insecticidal and antimicrobial properties, respectively.
The phenolic acids and flavonoids found in methanolic T. purpurea subsp. apollinea extract may have the potential to actively participate in the antioxidant and anticancer effects on the tested carcinoma cells. These phytochemical components were identified with the HPLC apparatus, which analysis showed the presence of phenolic acid (gallic acid), which has been reported to have antioxidant and anticancer activities [55,56]. Another phenolic acid identified in T. purpurea subsp. apollinea methanolic extract was ferulic acid, which has also been reported to have antioxidant and anticancer activities [65]. Chlorogenic acid [57], pyrocatechol [60], and coumaric acid [63] were the identified phenolic compounds in T. purpurea subsp. apollinea extract with antioxidant and anticancer properties. The identified gallate ester in the extract (methyl gallate) has also been reported to have antioxidant and anticancer activities [58]. Additionally, caffeic acid was the identified polyphenol, and it is known to exert antioxidative stress and anticancer activities [59]. The tannin (ellagic acid) also has antioxidant and anticancer potential [62]. The flavonoids rutin [61] and quercetin [68] have been reported to have antioxidant and anticancer properties. Additionally, naringenin [66] and hesperetin [72] were the identified flavanones known to have antioxidant and anticancer properties. These findings agree with the results reported in the literature where the flavanones (-)-pseudosemiglabrin isolated from T. apollinea, which has a close affiliation to T. purpurea subsp. apollinea showed anticancer effects against leukemia, breast, and prostate cancers [73]. Daidzein is an isoflavone that has also been reported to exert antioxidant and anticancer properties [67]. Cinnamic acid is monocarboxylic acid present in T. purpurea subsp. apollinea, and studies have shown that it has antioxidant and anticancer properties [69]. The phenolic aldehyde found in the extract with reported antioxidant and anticancer properties was vanillin [64]. Apigenin [70] and kaempferol [71] were the identified flavone and flavonol, respectively, and have been reported to have antioxidant and anticancer properties. These results agree with existing data on different extracts from T. apollina, which contained flavones (semiglabrin 1, pseudosemiglabrin 2, glabratephrin 3, and apollinine 4) [74]. Interestingly, these extracts showed various degrees of antioxidant and anticancer effects against hepatocellular carcinoma (HepG2), colorectal carcinoma (HC116), and prostate cancer (PC3) [74]. Additionally, another prenylated flavone (isoglabratephrin) isolated from T. apollinea showed anticancer activities against prostate cancer (PC3) and pancreatic cancer (PANC1) through induction of chromatin disruption and nuclear damage [75]. This is consistent with the anticancer effects of T. purpurea subsp. apollinea against breast cancer (MCF7), ductal breast cancer (T47D), osteosarcoma (MG63), cervical cancer (HeLa), and prostate cancer, as seen in this research. However, the anticancer effect was weak against leukemia, when compared with other cancer cell lines. Therefore, T. purpurea subsp. apollinea exerted anticancer impact on all cells investigated, except leukemia. However, the anticancer effects of T. purpurea subsp. apollinea were without any selective cytotoxicity to cancer cells, relative to non-cancer cell lines (WI38). In this study, T. purpurea subsp. apollinea methanolic extract also demonstrated potential dose-dependent antioxidant activities, when compared to ascorbic acid. This result is consistent with the findings of dose-dependent inhibition of DPPH radical by T. apollinea methanolic extract [76]. Additionally, different extracts of T. apollinea have been reported to have antioxidant activities when assessed for radical scavenging, TAC, anti-lipid peroxidation, and GSH level [77]. Therefore, T. purpurea subsp. apollinea may have potential antioxidant properties due to the various identified antioxidant compounds, and it may also have anticancer properties due to the presence of different anticancer compounds.

4. Materials and Methods

4.1. Plant Material

The aerial parts of T. purpurea subsp. apollinea were collected from the Al-Mansoura city (31°02′27.2″ N 31°22′42.6″ E), Delta region, Egypt, at the flowering stage in March 2022, and the voucher sample was kept at its herbarium (CAIH-21/23-5) in Cairo, Egypt after it was authenticated by a plant taxonomist Professor Iman Hussein Salama Al-Gohary. Following rinsing in running water and shade dehydration for 1 week and 3 days at 25 °C, the specimen was ground to powder [7].

4.2. Preparation of Methanolic Extract and GC-MS Studies

Utilizing the cold percolation method, 200 g of the above sample of the plant was subjected to extraction. Subsequently, the extract was exposed to three separate applications of 500 mL of 70% methanol for 72 h at 25 °C. The methanol extract was filtered using a Buchner funnel. Then, the remaining methanol was entirely removed from the methanol extract using a rotary evaporator and concentration at low pressure at 40 °C. The sediment was dried in a desiccator to produce a dry weight yield of 20.68 g/100 g of T. purpurea subsp. apollinea, and GC-MS analysis was employed to identify the bioactive components [7].
A TRACE 1310 gas chromatograph connected to an ISQLT MS single quadrupole mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) was used. The data were obtained from the GC-MS at 70 eV ionization voltage, EI ionization mode, DB5-MS column with an internal diameter of 0.25 mm (J & W Scientific, Folsom, CA, USA), and the temperature was programmed in this manner: 3 min at 40 °C, 5 min at 280 °C, 1 min at 290 °C and constant at 7.5 °C/min. The detector and injector temperatures were adjusted to be 300 and 200 °C, respectively. The flow rate of the carrying gas (helium) was constant at 1 mL/min. The WILEY and NIST Mass Spectral Data Base was used as a search library [7].

4.3. Sub-Fractionation Using n-Hexane and GC-MS Studies

In 250 mL of distilled water, 2.5 g of lyophilized crude methanolic extract of T. purpurea subsp. apollinea was re-dissolved. Then, for 24 h, the re-dissolved crude extract was separated with n-hexane using a separatory funnel, followed by the use of a rotating evaporator at a temperature of 40 °C and lower pressures to obtain the n-hexane layer in a dry form. A GC-MS analysis was performed on the dried portion (1 mg) [78,79].
A split-splitless injector was used in tandem with the Shimadzu GCMS-QP2010 (Shimadzu, Tokyo, Japan). The mass spectra were acquired using a Restek 30-m Rtx-5MS column with an internal diameter of 0.25 mm (Chrom Tech, Bellefonte, PA, USA). The starting temperature of the column was raised to 300 °C at a rate of 5 °C/min for 5 min and was then held constant there for 2 min (isothermal). The injector temperature was 250 °C. Helium carrier gas was at a flow rate of 1.41 mL per min. The ion source of 200 °C, ionization voltage of 70 eV, and filament emission current of 60 mA were applied to acquire all mass spectra. The sample (1% v/v) dilution injection was performed via a split mode [78].

4.4. Quantification of Phenolics and Flavonoids

Phenolics and flavonoids were quantified using the standard Folin–Ciocalteu technique [79,80]. The optical density of the bluish reaction solution was read at a maximum λmax of 725 nm after one hour using the Unicam UV-visible Spectrometer, with distilled H2O as blank. A calibration curve of gallic acid was plotted. The results were calculated in terms of milligrams of gallic acid equivalents (GAE) per gram dry weight [79,80].
The total flavonoid content was determined using an aluminum chloride colorimetric method [79,80]. The extract was diluted 1:6 (v:v) with distilled water, and the mixture was then added to 75 µL of NaNO2 (5%), followed by the addition of 10% AlCl3.6H2O (150 µL) after 6 min to the mixture and it was let to stand for an additional 5 min. After adding 1 M NaOH solution (0.5 mL), 2.5 mL of distilled water was added to the mixture. Optical density was recorded at 510 nm against a blank of distilled water. A standard calibration curve was developed using (+)-catechin. The findings were calculated as mg of catechin equivalents (CE) for each gram [79,80].

4.5. HPLC Analysis of Phenolic Compounds

4.5.1. Standards

The phenolic compounds were investigated with HPLC reagents (acetonitrile, methanol, and trifluoroacetic acid) purchased from SDS (Peypin, France). The distilled water was obtained from Milli-Q (Millipore, MA, USA). All standards used (methyl gallate, coffeic acid, etc.) were provided by Sigma (St. Louis, MO, USA) and had a 98% level of purity [79,80].

4.5.2. HPLC Quantitation of Phenolics

The MeOH extract of T. purpurea subsp. apollinea (0.20 g) was solubilized in 2 mL of acetonitrile. The identification of phenolic compounds was performed using an Agilent 1260 HPLC instrument (Agilent Technologies, Santa Clara, CA, USA). An Eclipse C18 column (4.6 mm × 250 mm i.d., 5 μm) was used to separate the phenolic compounds, with a mobile phase comprised of H2O (A) and CF3COOH (0.05%) in acetonitrile (B) at a flow rate of 0.9 mL/60 s.
A linear gradient was applied to configure the mobile phase. Sample monitoring was performed at 280 nm using a multiple λmax detector. For each sample solution, 5 µL was injected into the column at 40 °C. Standards were prepared as stock solutions of 10 mg/50 mL in methanol. Then, the standards were loaded into HPLC after being diluted. The flavonoids and phenolic acids in the methanolic extract from T. purpurea subsp. apollinea were identified and quantified using Equation (1), and the results were calculated in terms of mg/100 g dry weight [79,80].
  C o n c .   o f   t h e   i d e n t i f i e d   c o m p o u n d   ( μ g / mL )   = A r e a   o f   t h e   s a m p l e × C o n c .     ( μ g / mL ) o f   t h e   s t a n d a r d   A r e a   o f   t h e   s t a n d a r d                                          

4.6. Evaluation of Antioxidant Properties

4.6.1. DPPH Antioxidant Assay

The 2,2-diphenylpicrylhydrazyl (DPPH) neutralizing potential of methanol extract of T. purpurea subsp. apollinea was investigated. The methanolic extract of T. purpurea subsp. apollinea was serially diluted to various concentrations, i.e., 1.95, 3.9, 7.8, 15.6, 31.2, 62.5, 125, 250, 500, and 1000 µg/mL. Each methanolic extract concentration (1 mL) was added to 3 mL of 0.1 mM DPPH solubilized in methanol, followed by shaking and placing it into a dark chamber for 30 min. When DPPH reacts with an H-donating antioxidant, it is scavenged, thereby resulting in a decrease in absorbance [80]. The optical density of each concentration was measured at 517 nm in a UV-Vis spectrophotometer. Ascorbic acid was used as an antioxidant standard. All the values were measured in triplicate.

4.6.2. ABTS Antioxidant Assay

Distilled water was used to bring up a 50-mL volumetric flask to mark after dissolving 192 mg of 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) in a small volume of water and transferring it to the flask, followed by addition of 1 mL of this solution to 17 μL 0.14 M K2S2O8, and incubation in darkness for 24 h. To prepare the final ABTS dilution for the T. purpurea subsp. apollinea extract, 1 mL of reaction mixture was added to 49 mL of methanol. Then, 0.190 mL of newly made ABTS solution was mixed with 0.010 mL of plant extract in a 96-well plate and kept in the dark for 30 min. Thereafter, a decrease in ABTS OD was read at 734 nm in a FluoStar Omega microplate reader. Trolox was used as an antioxidant standard. All the values were measured in triplicate.

4.6.3. Measurement of IC50

The IC50 values of DPPH and ABTS antioxidant assays for samples and controls were calculated using GraphPad Prism 7. The IC50 values were calculated as shown in Equation (2):
I n h i b i t i o n   p e r c e n t = A v e r a g e   a b s o r b a n c e   o f   b l a n k − A v e r a g e   a b s o r b a n c e   o f   t e s t × 100        

4.7. Determination of Anticancer Effect

Breast cancer cell lines (MCF7), osteosarcoma (MG63), breast ductal carcinoma (T47D), leukemia (U937), as well as HeLa, PC3, and healthy pulmonary fibroblast were supplied by the tissue culture laboratory at Vacsera, Egypt. The culturing procedure was maintained sterile, utilizing a laminar airflow cabinet. The cells were cultured in Roswell Park Memorial Institute medium (RPMI 1640). The medium was provided with antibiotics (streptomycin and penicillin) as well as antifungal agents (amphotericin B) and l-glutamine. It was also supplemented with 10% heat-inactivated fetal bovine serum [80].

4.7.1. Viability Evaluation

Cell viability was measured using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The principle of the MTT assay is that through mitochondrial reduction, purple-colored crystals are produced from the yellowish MTT [80]. A 96-well microplate was used for inoculation, and 100 µL of the Roswell Park Memorial Institute medium (RPMI 1640) was added to each well. A fully formed monolayer sheet was produced by incubation of the microplate for 24 h at 5% CO2, 37 °C, and 95% humidity. When the cells had formed a confluent layer, the growth medium was discarded.
Using a growth medium, serial dilutions of the dimethyl sulfoxide (DMSO)-solubilized extract were produced at concentrations of 31.25, 62.5, 125, 250, 500, and 1000 µg/mL [80]. Using a multichannel pipette, the cells were transferred to 0.10 mL of each extract concentration in triplicate before being dispersed in 96-well plates, followed by incubation of the extract-treated cells for 24 h at 37 °C and 5% CO2. Control cells were incubated without the addition of the stem and leaf extracts. Thereafter, 20 µL of MTT solution (5 mg/mL) in PBS was added to each well, followed by mixing, which was performed for 5 min at 150 rpm. After that, incubation was maintained for 4 h. Then, the formazan crystals were taken up in 200 µL of DMSO and vigorously agitated. A microplate reader was used to measure the optical density of the formazan solution at 560 nm, with values corrected using a background reference λ of 620 nm [80]. Each experiment was performed three times.

4.7.2. Measurement of IC50

The IC50 profiles of methanol extract of T. purpurea subsp. apollinea and a positive control for cancer and healthy cell lines were determined with GraphPad Prism version 7 (GraphPad Software Inc., San Diego, CA, USA). The IC50 values were computed as shown in Equation (3) [80]. The data obtained were subjected to non-linear regression to obtain 50% effective concentrations (EC50) and cytotoxic concentration (CC50), with 95% confidence intervals.
Inhibition   percent = 100 − ( mean   OD   test ) Mean   OD   control × 100  

4.7.3. Classification of Cytotoxicity

The United States NCI and Geran guidelines were used to classify the cytotoxicity of T. purpurea subsp. apollinea methanol extract, based on IC50, with IC50 values ≤ 20, 21–200, 201–500, and >501 µg/mL classified as extremely-, mildly-, weakly-, and non-cytotoxic, respectively [81,82].

4.7.4. Criteria for Selectivity

The selectivity index (SI) is IC50 for a healthy cell (WI38) divided by IC50 for a cancerous cell. SI values less than 3 indicate non-specificity to cancer cells [81]. The SI values of methanolic extract of T. purpurea subsp. apollinea were calculated using Equation (3) as follows:
SI = IC 50   for   a   healthy   cell   ( WI 38 ) IC 50   for   a   cancerous   cell  

4.7.5. Microscopy

Morphologies of cells treated with the various methanol T. purpurea subsp. apollinea extract concentrations were investigated under light microscopy at 10× objective lens, total magnification = 100×.

5. Conclusions

Tephrosia purpurea subsp. apollinea contained various chemical compounds in the methanolic and n-hexane subfraction extracts. The major components that had antioxidant and anticancer properties were stigmasta- 14 5,24(28)-dien-3-ol, (3 β,24Z)-, 9,12,15-octadecatrienoic acid methyl ester, phytol, chlorogenic acid, and quercetin. Therefore, these chemical compounds may be isolated from T. purpurea subsp. apollinea and their antioxidant and anticancer properties may be investigated against breast cancer (MCF7), osteosarcoma (MG63), breast ductal carcinoma (T47D), cervical cancer (HeLa), and prostate cancer (PC3). However, the anticancer effect of Tephrosia purpurea subsp. apollinea was weak against leukemia (U937). Additionally, the healthy cell lines (WI-38) were not greatly affected by the Tephrosia purpurea subsp. apollinea cytotoxicity. Moreover, this is the first report on this plant, and it may be the foundation for further pharmacological studies.

Author Contributions

Conceptualization, A.M.M.Y.; Formal analysis, Y.M.A.-S.; Investigation, D.A.M.M.; Methodology, A.M.M.Y., D.A.M.M. and Y.M.A.-S.; Supervision, A.M.M.Y.; Writing—original draft, A.M.M.Y.; Writing—review and editing, A.M.M.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We want to thank Iman Al-Gohary of Plant Taxonomy, for identifying and collecting the T. purpurea subsp. apollinea plants.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the extracts are available from the authors.

References

  1. Baskar, R.; Lee, K.A.; Yeo, R.; Yeoh, K.-W. Cancer and radiation therapy: Current advances and future directions. Int. J. Med. Sci. 2012, 9, 193. [Google Scholar] [CrossRef] [PubMed]
  2. Al-Saraireh, Y.M.; Alshammari, F.O.; Youssef, A.M.; Al-Sarayreh, S.; Almuhaisen, G.H.; Alnawaiseh, N.; Al Shuneigat, J.M.; Alrawashdeh, H.M. Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers. Sci. Rep. 2021, 11, 5581. [Google Scholar] [CrossRef] [PubMed]
  3. Yang, C.; Mai, Z.; Liu, C.; Yin, S.; Cai, Y.; Xia, C. Natural products in preventing tumor drug resistance and related signaling pathways. Molecules 2022, 27, 3513. [Google Scholar] [CrossRef]
  4. Al-Saraireh, Y.M.; Alshammari, F.O.; Youssef, A.M.; Al-Sarayra, Y.M.; Al-Saraireh, R.A.; Al-Muhaisen, G.H.; Al-Mahdy, Y.S.; Al-Kharabsheh, A.M.; Abufraijeh, S.M.; Alrawashdeh, H.M. Cytochrome 4Z1 expression is correlated with poor prognosis in patients with cervical cancer. Curr. Oncol. 2021, 28, 3573–3584. [Google Scholar] [CrossRef]
  5. Al-Saraireh, Y.M.; Alshammari, F.O.; Youssef, A.M.; Al-Sarayreh, S.; Al-Sarayra, Y.M.; Aborajooh, E.; Al-Shuneigat, J.; Alrawashdeh, H.M. Screening of glypican-6 expression in benign, primary and metastatic colon cancers. Clin. Med. Insights Oncol. 2021, 15, 11795549211036419. [Google Scholar] [CrossRef] [PubMed]
  6. Alshammari, F.O.; Al-Saraireh, Y.M.; Youssef, A.M.; Al-Sarayra, Y.M.; Alrawashdeh, H.M. Glypican-1 Overexpression in Different Types of Breast Cancers. Onco Targets Ther. 2021, 14, 4309. [Google Scholar] [CrossRef] [PubMed]
  7. Youssef, A.M.; Maaty, D.A.; Al-Saraireh, Y.M. Phytochemical Analysis and Profiling of Antitumor Compounds of Leaves and Stems of Calystegia silvatica (Kit.) Griseb. Molecules 2023, 28, 630. [Google Scholar] [CrossRef] [PubMed]
  8. Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709. [Google Scholar] [CrossRef]
  9. Murphy, M.P.; Bayir, H.; Belousov, V.; Chang, C.J.; Davies, K.J.; Davies, M.J.; Dick, T.P.; Finkel, T.; Forman, H.J.; Janssen-Heininger, Y. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat. Metab. 2022, 4, 651–662. [Google Scholar] [CrossRef]
  10. Akbari, B.; Baghaei-Yazdi, N.; Bahmaie, M.; Mahdavi Abhari, F. The role of plant-derived natural antioxidants in reduction of oxidative stress. BioFactors 2022, 48, 611–633. [Google Scholar] [CrossRef]
  11. Ayoka, T.O.; Ezema, B.O.; Eze, C.N.; Nnadi, C.O. Antioxidants for the Prevention and Treatment of Non-communicable Diseases. J. Explor. Res. Pharmacol. 2022, 7, 178–188. [Google Scholar] [CrossRef]
  12. Hussein, R.M.; Youssef, A.M.; Magharbeh, M.K.; Al-Dalaen, S.M.; Al-Jawabri, N.A.; Al-Nawaiseh, T.N.; Al-Jwanieh, A.; Al-Ani, F.S. Protective Effect of Portulaca oleracea Extract Against Lipopolysaccharide-Induced Neuroinflammation, Memory Decline, and Oxidative Stress in Mice: Potential Role of miR-146a and miR-let 7. J. Med. Food 2022, 25, 807–817. [Google Scholar] [CrossRef] [PubMed]
  13. Boulos, L. Flora of Egypt; Al Hadara Publishing: Cairo, Egypt, 1999; Volume 1. [Google Scholar]
  14. Samuel, V.J.; Mahesh, A.R.; Murugan, V. Phytochemical and pharmacological aspects of Tephrosia genus: A brief review. J. Appl. Pharm. Sci. 2019, 9, 117–125. [Google Scholar]
  15. Gulecha, V.; Sivakuma, T. Anticancer activity of Tephrosia purpurea and Ficus religiosa using MCF 7 cell lines. Asian Pac. J. Trop. Med. 2011, 4, 526–529. [Google Scholar] [CrossRef] [PubMed]
  16. Chen, Y.; Yan, T.; Gao, C.; Cao, W.; Huang, R. Natural products from the genus Tephrosia. Molecules 2014, 19, 1432–1458. [Google Scholar] [CrossRef]
  17. Dahham, S.S.; Tabana, Y.M.; Iqbal, M.A.; Ahamed, M.B.; Ezzat, M.O.; Majid, A.S.; Majid, A.M. The anticancer, antioxidant and antimicrobial properties of the sesquiterpene β-caryophyllene from the essential oil of Aquilaria crassna. Molecules 2015, 20, 11808–11829. [Google Scholar] [CrossRef]
  18. Fafal, T.; Tüzün, B.S.; KIVÇAK, B. Fatty Acid Compositions and Antioxidant Activities of Ranunculus isthmicus subsp. tenuifolius and Ranunculus rumelicus. Int. J. Nat. Life Sci. 2022, 6, 151–159. [Google Scholar] [CrossRef]
  19. Ibrahim, O.H.; Al-Qurashi, A.D.; Asiry, K.A.; Mousa, M.A.; Alhakamy, N.A.; Abo-Elyousr, K.A. Investigation of Potential In Vitro Anticancer and Antimicrobial Activities of Balanites aegyptiaca (L.) Delile Fruit Extract and Its Phytochemical Components. Plants 2022, 11, 2621. [Google Scholar] [CrossRef]
  20. Elsharkawy, E.R.; Alghanem, S.M.; Elmorsy, E. Effect of habitat variations on the chemical composition, antioxidant, and antimicrobial activities of Achillea fragrantissima (Forssk) Sch. Bip. Biotechnol. Rep. 2021, 29, e00581. [Google Scholar] [CrossRef]
  21. Kumar, P.; Sati, S.; Khulbe, K.; Pant, P.; Tripathi, A.N.; Sarvendra, K. Phytochemical constituents, antimicrobial and antioxidant activities of Kumaun Himalayan Hoop Pine bark extract. Nat. Prod. Res. 2022, 36, 1095–1099. [Google Scholar] [CrossRef]
  22. Kumar, R.S.; Anburaj, G.; Subramanian, A.; Vasantha, S.; Selvam, A.P. Preliminary phytochemical investigation, Antimicrobial activity and GC-MS analysis of leaf extract of Capparis zeylanica Linn. J. Pharm. Phytochem 2019, 8, 1399–1405. [Google Scholar]
  23. Belakhdar, G.; Benjouad, A.; Abdennebi, E. Determination of some bioactive chemical constituents from Thesium humile Vahl. J. Mater. Environ. Sci. 2015, 6, 2778–2783. [Google Scholar]
  24. Rakkimuthu, R.; Ananthi, P.; Sathishkumar, P.; Ananda kumar, A.M.; Sowmiya, D. Chemical profiling of fern Cheilosoria mysurensis (Wall. ex Hook.) Ching & Shing and its biological activity. Plant Sci. Today 2023, 10, 91–95. [Google Scholar] [CrossRef]
  25. Mohamed, N.T. Seperation of bioactive compounds from Haemolymph of scarab beetle Scarabaeus sacer (Coleoptera: Scarabaeidae) by GC-MS and determination of its antimicrobial activity. Int. J. Appl. Biol. 2021, 5, 98–116. [Google Scholar] [CrossRef]
  26. Harun, A.; Aziz, N.A.; Azenan, N.S.M.; Kamarazzaman, N.F.M.; So’ad, S.Z.M. Antimicrobial Efficacy, Antioxidant Profile and Nine Alternative Active Constituents from Petroleum Ether and Ethyl Acetate Extract of Entada spiralis. Malays. J. Anal. Sci. 2020, 24, 707–718. [Google Scholar]
  27. Hussein, H.J.; Hameed, I.H.; Hadi, M.Y. Using gas chromatography-mass spectrometry (GC-MS) technique for analysis of bioactive compounds of methanolic leaves extract of Lepidium sativum. Res. J. Pharm. Technol. 2017, 10, 3981–3989. [Google Scholar] [CrossRef]
  28. Rautela, I.; Dheer, P.; Thapliyal, P.; Joshi, T.; Sharma, N.; Sharma, M.D. GC-MS analysis of plant leaf extract of Datura stramonium in different solvent system. Eur. J. Biomed. Pharm. Sci 2018, 5, 236–245. [Google Scholar]
  29. Khan, N.; Ali, A.; Qadir, A.; Ali, A.; Warsi, M.H.; Tahir, A.; Ali, A. GC-MS analysis and antioxidant activity of Wrightia tinctoria R. Br. leaf extract. J. AOAC Int. 2021, 104, 1415–1419. [Google Scholar] [CrossRef]
  30. Abdelhamid, M.S.; Kondratenko, E.I.; Lomteva, N.A. GC-MS analysis of phytocomponents in the ethanolic extract of Nelumbo nucifera seeds from Russia. J. Appl. Pharm. Sci. 2015, 5, 115–118. [Google Scholar] [CrossRef]
  31. Morah, F.N.; Uduagwu, D.N. Chemical composition, antioxidant and larvicidal activity of Alchornea laxiflora (Benth) leaf extracts. Edorium J. Pharmacol. 2017, 1, 1–8. [Google Scholar]
  32. Dawoud, S.F.; Al-Akra, T.; Zedan, A.M. Antioxidant Activity of Some Natural Compounds in Alleviating the Hepatotoxicity Effects Induced by Emamectin Benzoate in Male Mice. J. Agric. Chem. Biotechnol. 2021, 12, 145–156. [Google Scholar] [CrossRef]
  33. Emam, K.K.; Abdel Fattah, M.E.; El Rayes, S.M.; Hebishy, M.A.; Dessouki, A.A. Assessment of Wheat Germ Oil Role in the Prevention of Induced Breast Cancer in Rats. ACS Omega 2022, 7, 13942–13952. [Google Scholar] [CrossRef] [PubMed]
  34. Ali, H.A.-M.; Mohammed, Y.H.; Imad, H.H. Determination of metabolites products by Cassia angustifolia and evaluate antimicobial activity. J. Pharmacogn. Phytother. 2016, 8, 25–48. [Google Scholar] [CrossRef]
  35. Chen, Y.-F.; Wu, K.-J.; Siao, L.-R.; Tsai, H.-Y. Trilinolein, a Natural Triacylglycerol, Protects Cerebral Ischemia through Inhibition of Neuronal Apoptosis and Ameliorates Intimal Hyperplasia via Attenuation of Migration and Modulation of Matrix Metalloproteinase-2 and RAS/MEK/ERK Signaling Pathway in VSMCs. Int. J. Mol. Sci. 2022, 23, 12820. [Google Scholar] [CrossRef]
  36. Ould Bellahcen, T.; Cherki, M.; Sánchez, J.A.C.; Cherif, A.; El Amrani, A. Chemical composition and antibacterial activity of the essential oil of Spirulina platensis from Morocco. J. Essent. Oil Bear. Plants 2019, 22, 1265–1276. [Google Scholar] [CrossRef]
  37. Varsha, K.K.; Devendra, L.; Shilpa, G.; Priya, S.; Pandey, A.; Nampoothiri, K.M. 2, 4-Di-tert-butyl phenol as the antifungal, antioxidant bioactive purified from a newly isolated Lactococcus sp. Int. J. Food Microbiol. 2015, 211, 44–50. [Google Scholar] [CrossRef]
  38. Zhou, C.; Li, C.; Siva, S.; Cui, H.; Lin, L. Chemical composition, antibacterial activity and study of the interaction mechanisms of the main compounds present in the Alpinia galanga rhizomes essential oil. Ind. Crops Prod. 2021, 165, 113441. [Google Scholar] [CrossRef]
  39. Gazwi, H.S.; Shoeib, N.A.; Mahmoud, M.E.; Soltan, O.I.; Hamed, M.M.; Ragab, A.E. Phytochemical Profile of the Ethanol Extract of Malvaviscus arboreus Red Flower and Investigation of the Antioxidant, Antimicrobial, and Cytotoxic Activities. Antibiotics 2022, 11, 1652. [Google Scholar] [CrossRef]
  40. Subash, N.; Raju, G. GC-MS analysis and antibacterial activity of Stem of Indigofera longeracemosa Boiv. Ex Baill. Nat. Pharm. Technol. 2014, 4, 1–6. [Google Scholar]
  41. Rhetso, T.; Shubharani, R.; Roopa, M.; Sivaram, V. Chemical constituents, antioxidant, and antimicrobial activity of Allium chinense G. Don. Future J. Pharm. Sci. 2020, 6, 102. [Google Scholar] [CrossRef]
  42. Sunita, A.; Ganesh, K.; Sonam, M. Screening and evaluation of bioactive components of Cenchrus ciliaris L. by GC-MS analysis. Int. Res. J. Pharm. 2017, 8, 69–76. [Google Scholar]
  43. Shariare, M.H.; Noor, H.B.; Khan, J.H.; Uddin, J.; Ahamad, S.R.; Altamimi, M.A.; Alanazi, F.K.; Kazi, M. Liposomal drug delivery of Corchorus olitorius leaf extract containing phytol using design of experiment (DoE): In-vitro anticancer and in-vivo anti-inflammatory studies. Colloids Surf. B. Biointerfaces 2021, 199, 111543. [Google Scholar] [CrossRef] [PubMed]
  44. Okpala, E.O.; Onocha, P.A.; Ali, M.S. Antioxidant activity of phytol dominated stem bark and leaf essential oils of Celtis zenkeri Engl. Trends Phytochem. Res. 2022, 6, 137–144. [Google Scholar]
  45. Abdel-Hady, H.; El-Wakil, E.A.; Abdel-Gawad, M. GC-MS analysis, antioxidant and cytotoxic activities of Mentha spicata. Eur. J. Med. Plants 2018, 26, 1–12. [Google Scholar] [CrossRef]
  46. Faridha Begum, I.; Mohankumar, R.; Jeevan, M.; Ramani, K. GC–MS analysis of bio-active molecules derived from Paracoccus pantotrophus FMR19 and the antimicrobial activity against bacterial pathogens and MDROs. Indian J. Microbiol. 2016, 56, 426–432. [Google Scholar] [CrossRef]
  47. Neveen, M.K.; Emad, A.S.; Dalia, M.A.; Enas, M.A.; Ahmed, M.A.-E. Biological activities of secondary metabolites from Emericella nidulans EGCU 312. Afr. J. Microbiol. Res. 2014, 8, 2011–2021. [Google Scholar] [CrossRef]
  48. Kotteswari, M.; Prabhu, K.; Rao, M.R.K.; Ahamed, A.; Balaji, T.; Dinakar, S.; Sundaram, R.L. The gas chromatography-mass spectrometry study of one Ayurvedic formulation avipathi churnam. Drug Invent. Today 2020, 13, 668–671. [Google Scholar]
  49. Zubair, M.F.; Ajibade, S.O.; Lawal, A.Z.; Yusuf, S.A.; Babalola, J.B.; Mukadam, A.A.; Hamid, A.A. GC-MS analysis, Antioxidant and Antimicrobial Properties of Eclipta prostrata leaves. Int. J. Chem. Biochem. Sci. 2017, 11, 25–43. [Google Scholar]
  50. Radman, S.; Čižmek, L.; Babić, S.; Cikoš, A.-M.; Čož-Rakovac, R.; Jokić, S.; Jerković, I. Bioprospecting of less-polar fractions of Ericaria crinita and Ericaria amentacea: Developmental Toxicity and antioxidant activity. Mar. Drugs 2022, 20, 57. [Google Scholar] [CrossRef]
  51. Anita, A.; Selvaraj, D. In silico molecular docking study of plant-based compounds from medicinal plant Lantana camara L. against Aedes aegypti L. protein. Int. J. Mosq. Res. 2022, 9, 97–106. [Google Scholar] [CrossRef]
  52. El-Sayed, O.H.; Asker, M.M.; Shash, S.M.; Hamed, S.R. Isolation, structure elucidation and biological activity of Di-(2-ethylhexyl) phthalate produced by Penicillium janthinellum 62. Int. J. Chem. Tech. Res. 2015, 8, 58–66. [Google Scholar]
  53. Habib, M.R.; Karim, M.R. Antitumour evaluation of di-(2-ethylhexyl) phthalate (DEHP) isolated from Calotropis gigantea L. flower/Evaluacija antitumorskog djelovanja di-(2-etilheksil)-ftalata (DEHP) izoliranog iz cvjetova Calotropis gigantea L. Acta Pharm. 2012, 62, 607–615. [Google Scholar] [CrossRef] [PubMed]
  54. Sirikhansaeng, P.; Tanee, T.; Sudmoon, R.; Chaveerach, A. Major phytochemical as γ-sitosterol disclosing and toxicity testing in Lagerstroemia species. Evid.-Based Complement. Altern. Med. 2017, 2017, 7209851. [Google Scholar] [CrossRef] [PubMed]
  55. Jiang, Y.; Pei, J.; Zheng, Y.; Miao, Y.-j.; Duan, B.-z.; Huang, L.-f. Gallic Acid: A Potential Anti-Cancer Agent. Chin. J. Integr. Med. 2021, 28, 661–671. [Google Scholar] [CrossRef]
  56. Zhang, X.; Liu, J.; Qian, C.; Kan, J.; Jin, C. Effect of grafting method on the physical property and antioxidant potential of chitosan film functionalized with gallic acid. Food Hydrocoll. 2019, 89, 1–10. [Google Scholar] [CrossRef]
  57. Wang, L.; Pan, X.; Jiang, L.; Chu, Y.; Gao, S.; Jiang, X.; Zhang, Y.; Chen, Y.; Luo, S.; Peng, C. The biological activity mechanism of chlorogenic acid and its applications in food industry: A review. Front. Nutr. 2022, 9, 943911. [Google Scholar] [CrossRef]
  58. Lee, S.-H.; Kim, J.K.; Kim, D.W.; Hwang, H.S.; Eum, W.S.; Park, J.; Han, K.H.; Oh, J.S.; Choi, S.Y. Antitumor activity of methyl gallate by inhibition of focal adhesion formation and Akt phosphorylation in glioma cells. Biochim. Et Biophys. Acta (BBA)-Gen. Subj. 2013, 1830, 4017–4029. [Google Scholar] [CrossRef]
  59. Espíndola, K.M.M.; Ferreira, R.G.; Narvaez, L.E.M.; Silva Rosario, A.C.R.; Da Silva, A.H.M.; Silva, A.G.B.; Vieira, A.P.O.; Monteiro, M.C. Chemical and pharmacological aspects of caffeic acid and its activity in hepatocarcinoma. Front. Oncol. 2019, 9, 541. [Google Scholar] [CrossRef]
  60. Azaat, A.; Babojian, G.; Nizar, I. Phytochemical Screening, Antioxidant and Anticancer Activities of Euphorbia hyssopifolia L. against MDA-MB-231 Breast Cancer Cell Line. J. Turk. Chem. Soc. Sect. A Chem. 2022, 9, 295–310. [Google Scholar] [CrossRef]
  61. Gullón, B.; Lú-Chau, T.A.; Moreira, M.T.; Lema, J.M.; Eibes, G. Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability. Trends Food Sci. Technol. 2017, 67, 220–235. [Google Scholar] [CrossRef]
  62. Sepúlveda, L.; Ascacio, A.; Rodríguez-Herrera, R.; Aguilera-Carbó, A.; Aguilar, C.N. Ellagic acid: Biological properties and biotechnological development for production processes. Afr. J. Biotechnol. 2011, 10, 4518–4523. [Google Scholar]
  63. Pei, K.; Ou, J.; Huang, J.; Ou, S. p-Coumaric acid and its conjugates: Dietary sources, pharmacokinetic properties and biological activities. J. Sci. Food Agric. 2016, 96, 2952–2962. [Google Scholar] [CrossRef] [PubMed]
  64. Arya, S.S.; Rookes, J.E.; Cahill, D.M.; Lenka, S.K. Vanillin: A review on the therapeutic prospects of a popular flavouring molecule. Adv. Tradit. Med. 2021, 21, 1–17. [Google Scholar] [CrossRef]
  65. Kim, J.K.; Park, S.U. A recent overview on the biological and pharmacological activities of ferulic acid. Excli J. 2019, 18, 132–138. [Google Scholar]
  66. Zhao, Y.; Liu, S. Bioactivity of naringin and related mechanisms. Die Pharm.-Int. J. Pharm. Sci. 2021, 76, 359–363. [Google Scholar]
  67. Alshehri, M.M.; Sharifi-Rad, J.; Herrera-Bravo, J.; Jara, E.L.; Salazar, L.A.; Kregiel, D.; Uprety, Y.; Akram, M.; Iqbal, M.; Martorell, M. Therapeutic potential of isoflavones with an emphasis on daidzein. Oxid. Med. Cell. Longev. 2021, 2021, 6331630. [Google Scholar] [CrossRef] [PubMed]
  68. David, A.V.A.; Arulmoli, R.; Parasuraman, S. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharm. Rev. 2016, 10, 84. [Google Scholar]
  69. Ruwizhi, N.; Aderibigbe, B.A. Cinnamic acid derivatives and their biological efficacy. Int. J. Mol. Sci. 2020, 21, 5712. [Google Scholar] [CrossRef] [PubMed]
  70. Sen, P.; Sahu, P.K.; Haldar, R.; Sahu, K.; Prasad, P.; Roy, A. Apigenin naturally occurring flavonoids: Occurrence and bioactivity. Pharm. Biosci. J. 2016, 4, 56–68. [Google Scholar]
  71. Bangar, S.P.; Chaudhary, V.; Sharma, N.; Bansal, V.; Ozogul, F.; Lorenzo, J.M. Kaempferol: A flavonoid with wider biological activities and its applications. Crit. Rev. Food Sci. Nutr. 2022, 1–25. [Google Scholar] [CrossRef]
  72. Choi, S.-S.; Lee, S.-H.; Lee, K.-A. A Comparative Study of Hesperetin, Hesperidin and Hesperidin Glucoside: Antioxidant, Anti-Inflammatory, and Antibacterial Activities In Vitro. Antioxidants 2022, 11, 1618. [Google Scholar] [CrossRef] [PubMed]
  73. Ahmed Hassan, L.E.; Khadeer Ahamed, M.B.; Abdul Majid, A.S.; Iqbal, M.A.; Al Suede, F.S.R.; Haque, R.A.; Ismail, Z.; Ein, O.C.; Majid, A.M.S.A. Crystal structure elucidation and anticancer studies of (-)-pseudosemiglabrin: A flavanone isolated from the aerial parts of Tephrosia apollinea. PLoS ONE 2014, 9, e90806. [Google Scholar] [CrossRef] [PubMed]
  74. Azeez, K.O.; Shaker, N.M.; ElShamy, M.M.; Mogib, M.A. Phytochemical and Biological Evaluation of Tephrosia apollinea. Res. J. Pharm. Biol. Chem. Sci. 2015, 6, 195–202. [Google Scholar]
  75. Hassan, E.A.; Adnan Iqbal, M.; S Dahham, S.; M Tabana, Y.; B Khadeer Ahamed, M.; MS Abdul Majid, A. Colorectal, prostate and pancreas human cancers targeted bioassay-guided isolations and characterization of chemical constituents from Tephrosia apollinea. Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem.-Anti-Cancer Agents) 2017, 17, 590–598. [Google Scholar]
  76. Cheruth, A.J.; Al Baloushi, S.A.; Karthishwaran, K.; Maqsood, S.; Kurup, S.S.; Sakkir, S. Medicinally active principles analysis of Tephrosia apollinea (Delile) DC. growing in the United Arab Emirates. BMC Res. Notes 2017, 10, 61. [Google Scholar] [CrossRef] [PubMed]
  77. Rizvi, T.S.; Khan, A.L.; Ali, L.; Al-Mawali, N.; Mabood, F.; Hussain, J.; Adnan, M.; Al-Harrasi, A. In vitro oxidative stress regulatory potential of Citrullus colocynthis and Tephrosia apollinea. Acta Pharm. 2018, 68, 235–242. [Google Scholar] [CrossRef]
  78. Youssef, A.M.M.; EL-Swaify, Z.A.S.; Maaty, D.A.; Youssef, M.M. Phytochemistry and Antiviral Properties of Two Lotus Species Growing in Egypt. Vitae 2021, 28, 348069. [Google Scholar] [CrossRef]
  79. Youssef, A.M.M.; El-Swaify, Z.A.S. Anti-Tumour Effect of two Persicaria species seeds on colon and prostate cancers. Biomed. Pharmacol. J. 2018, 11, 635–644. [Google Scholar] [CrossRef]
  80. Youssef, A.; El-Swaify, Z.; Maaty, D.; Youssef, M. Comparative study of two Lotus species: Phytochemistry, cytotoxicity and antioxidant capacity. J. Pharm. Pharmacogn. Res. 2020, 8, 537–548. [Google Scholar]
  81. Al-saraireh, Y.M.; Youssef, A.M.; Alshammari, F.O.; Al-Sarayreh, S.A.; Al-Shuneigat, J.M.; Alrawashdeh, H.M.; Mahgoub, S.S. Phytochemical characterization and anti-cancer properties of extract of Ephedra foeminea (Ephedraceae) aerial parts. Trop. J. Pharm. Res. 2021, 20, 1675–1681. [Google Scholar] [CrossRef]
  82. Al-Saraireh, Y.M.; Youssef, A.M.; Alsarayreh, A.; Al Hujran, T.A.; Al-Sarayreh, S.; Al-Shuneigat, J.M.; Alrawashdeh, H.M. Phytochemical and anti-cancer properties of Euphorbia hierosolymitana Boiss. crude extracts. J. Pharm. Pharmacogn. Res. 2021, 9, 13–23. [Google Scholar] [CrossRef] [PubMed]
Molecules 28 03939 g001 550
Figure 1. The spectra of methanol extract of T. purpurea subsp. apollinea using gas chromatography/mass spectrometry.
Figure 1. The spectra of methanol extract of T. purpurea subsp. apollinea using gas chromatography/mass spectrometry.
Molecules 28 03939 g001
Molecules 28 03939 g002 550
Figure 2. The chemical structures of the chemical compounds identified from methanol extracts from T. purpurea subsp. apollinea via GC/MS.
Figure 2. The chemical structures of the chemical compounds identified from methanol extracts from T. purpurea subsp. apollinea via GC/MS.
Molecules 28 03939 g002
Molecules 28 03939 g003 550
Figure 3. The spectra of n-hexane extract of T. purpurea subsp. apollinea via gas chromatography/mass spectrometry.
Figure 3. The spectra of n-hexane extract of T. purpurea subsp. apollinea via gas chromatography/mass spectrometry.
Molecules 28 03939 g003
Molecules 28 03939 g004 550
Figure 4. The chemical structures of the chemical compounds identified from n-hexan subfraction extract from T. purpurea subsp. apollinea via GC/MS.
Figure 4. The chemical structures of the chemical compounds identified from n-hexan subfraction extract from T. purpurea subsp. apollinea via GC/MS.
Molecules 28 03939 g004
Molecules 28 03939 g005 550
Figure 5. The HPLC chromatogram of methanol extract of T. purpurea subsp. apollinea (A) Standard chromatogram; (B) T. purpurea subsp. apollinea chromatogram.
Figure 5. The HPLC chromatogram of methanol extract of T. purpurea subsp. apollinea (A) Standard chromatogram; (B) T. purpurea subsp. apollinea chromatogram.
Molecules 28 03939 g005
Molecules 28 03939 g006 550
Figure 6. Determination of the half-maximal inhibitory concentration (IC50) of DPPH and ABTS radical scavenging activities of methanolic extract of T. purpurea subsp. apollinea, ascorbic acid, and trolox.
Figure 6. Determination of the half-maximal inhibitory concentration (IC50) of DPPH and ABTS radical scavenging activities of methanolic extract of T. purpurea subsp. apollinea, ascorbic acid, and trolox.
Molecules 28 03939 g006
Molecules 28 03939 g007 550
Figure 7. Determination of the half-maximal inhibitory concentration (IC50) of T. purpurea subsp. apollinea extract against breast cancer (MCF-7).
Figure 7. Determination of the half-maximal inhibitory concentration (IC50) of T. purpurea subsp. apollinea extract against breast cancer (MCF-7).
Molecules 28 03939 g007
Molecules 28 03939 g008 550
Figure 8. Anticancer effects of T. purpurea subsp. apollinea methanolic extract on cancer cell lines. (A) Complete monolayer sheets are seen in all cancer cell lines that have not been treated; (B) Doxorubicin (250 µg/mL) treatment results in rounded and shrunk cells in all cancer cell lines; (C) Shrunk cells are observed in MCF7, MG63, T47D, HeLa, and PC3 cell lines treated with T. purpurea subsp. apollinea (250 µg/mL); however, small morphological changes in WI38 are observed. The scale bar = 100 µm.
Figure 8. Anticancer effects of T. purpurea subsp. apollinea methanolic extract on cancer cell lines. (A) Complete monolayer sheets are seen in all cancer cell lines that have not been treated; (B) Doxorubicin (250 µg/mL) treatment results in rounded and shrunk cells in all cancer cell lines; (C) Shrunk cells are observed in MCF7, MG63, T47D, HeLa, and PC3 cell lines treated with T. purpurea subsp. apollinea (250 µg/mL); however, small morphological changes in WI38 are observed. The scale bar = 100 µm.
Molecules 28 03939 g008
Molecules 28 03939 g009 550
Figure 9. An example of anticancer effect of T. purpurea subsp. apollinea methanolic extract on breast cancer cell line (MCF7). (A) Complete monolayer sheets of breast cancer cells (MCF7) that have not been treated; (B) The effect of doxorubicin treatment at different concentrations; (C) The effect of T. purpurea subsp. apollinea extract on MCF7 cell lines at different concentrations; (D) The effect of T. purpurea subsp. apollinea extract on normal human fetal lung fibroblast (WI38). The scale bar = 100 µm.
Figure 9. An example of anticancer effect of T. purpurea subsp. apollinea methanolic extract on breast cancer cell line (MCF7). (A) Complete monolayer sheets of breast cancer cells (MCF7) that have not been treated; (B) The effect of doxorubicin treatment at different concentrations; (C) The effect of T. purpurea subsp. apollinea extract on MCF7 cell lines at different concentrations; (D) The effect of T. purpurea subsp. apollinea extract on normal human fetal lung fibroblast (WI38). The scale bar = 100 µm.
Molecules 28 03939 g009
Molecules 28 03939 g010 550
Figure 10. (A) The effects of T. purpurea subsp. apollinea methanolic extract on breast cancer (MCF7), osteosarcoma (MG63), breast ductal carcinoma (T47D), cervical cancer (HeLa), prostate cancer (PC3), leukemia (U937), and normal human fetal lung fibroblast (WI38). (B) The effect of doxorubicin on cancer cell lines.
Figure 10. (A) The effects of T. purpurea subsp. apollinea methanolic extract on breast cancer (MCF7), osteosarcoma (MG63), breast ductal carcinoma (T47D), cervical cancer (HeLa), prostate cancer (PC3), leukemia (U937), and normal human fetal lung fibroblast (WI38). (B) The effect of doxorubicin on cancer cell lines.
Molecules 28 03939 g010
Table
Table 1. Biological compounds identification of methanol extract of T. purpurea subsp. apollinea by GC/MS.
Table 1. Biological compounds identification of methanol extract of T. purpurea subsp. apollinea by GC/MS.
CompoundsMWM.F.CategoryRtRA%Biological
Activities 		References
1Benzene,
1-methoxy-4-(1-propenyl)-		148C10H12OAromatic organic compound9.585.88No data available
2β-Caryophyllene204C15H24Sesquiterpenoid15.042.31Antioxidant and
Anticancer		[17]
3Palmitic Acid methyl
ester		270C17H34O2Fatty acid methyl ester26.304.06Antioxidant and
Anticancer		[18,19]
4Pseudosolasodine
diacetate		499C31H49NO4Alkaloid
Compound		27.401.55Antioxidant[20]
5Androstan-17-one,
3-ethyl-3-hydroxy-, (5alpha)		318C21H34O2Steroid 28.801.20Antioxidant
and
Antibacterial 		[21]
69,12-octadecadienoic acid,
Methyl ester		294C19H34O2Fatty acid methyl ester29.433.28Anticancer[22]
710-Octadecenoic acid, methyl ester296C19H36O2Fatty acid methyl ester29.574.31Antioxidant [23]
8Oxiraneundecanoic acid, 3-pentyl-,
Methyl ester, trans-		312C19H36O3Fatty acid methyl esters30.090.99Antioxidant and
Anticancer		[24]
9Ethyl iso-allocholate436C26H44O5Steroid 33.009.43Antioxidant [25]
103’,8,8’-Trimethoxy-3-piperidyl-2,2’-binaphthalene-1,1’,4,4’-tetrone487C28H25NO7Oxygen organic compound36.755.99Antioxidant and
antimicrobial		[26]
11Cholest-5-en-3-ol, 24-propylidene-, (3 alpha)-426C30H50OFatty acid37.450.65Antibacterial [27]
12Stigmasta-5,24(28)-dien-3-ol, (3 β,24Z)-412C29H48OSteroid37.7538.74Antioxidant[28]
13Olean-12-en-28-oic acid440C30H48O2Triterpenoids38.501.82No data available
14Flavone
4’-OH,5-OH,7-di-O-glucoside		594C27H30O15Isoflavonoid 40.362.49Antioxidant
and
Anticancer 		[29,30]
15Rhodopin554C40H58OCarotene 40.512.30Antioxidant[31]
161-heptatriacotanol537C37H76OAlcoholic
compound		40.843.85Antioxidant and
Anticancer 		[32]
17Glycidyl oleate338C21H38O3Ester 42.513.74Anticancer [33]
189-Octadecenoic acid,
1,2,3-propanetriyl ester		884C57H104O6Triglyceride 42.933.45Antioxidant
and immune modulators		[34,35]
191,3-Dielaidin620C39H72O5Glycerol Derivatives43.701.87No data available
Table
Table 2. Biological compounds identification of n-hexane extract of T. purpurea subsp. apollinea using GC/MS.
Table 2. Biological compounds identification of n-hexane extract of T. purpurea subsp. apollinea using GC/MS.
CompoundsMWM.F.CategoryRtRA%Biological
Activities		References
1Tetradecane198C14H30Alkane21.640.08Antibacterial [36]
22,4-Di-tert-butylphenol206C14H22OPhenol23.990.08Antioxidant[37]
3Pentadecane212C15H32Alkane24.260.20Antibacterial [38]
4Hexadecanoic acid, methyl ester270C17H34O2Fatty acid methyl esters33.620.37Antioxidant[39]
5Pentafluoropropionic acid, octadecyl ester416C21H37F5O2Ester35.240.17Antibacterial[40]
6Heneicosane296C21H44Aliphatic hydrocarbon35.420.60Pesticidal[41]
79,12,15-Octadecatrienoic acid, methyl ester292C19H32O2Fatty acid methyl ester36.860.67Anticancer[42]
8Phytol296C20H40OAcyclic diterpene alcohol37.310.61Antioxidant and
anticancer		[43,44]
9Methyl stearate298C19H38O2Fatty acid methyl ester 37.520.07Antioxidants and anticancer[45]
101-Heptacosanol396C27H56OLong-chain fatty
alcohol		39.020.43Antioxidant [46]
11Tributyl acetylcitrate402C20H34O8Organic compound39.540.04Antimicrobial [47]
12cis-5,8,11-Eicosatrienoic acid, methyl ester320C21H36O2Fatty acid methyl ester 40.6310.08Anti-inflammatory[48]
132-Methyltetracosane352C25H52Alkane40.950.18Antibacterial [49]
14Palmitoleamide253C16H31NOFatty acid amide41.160.13Antioxidant [50]
15Acetic acid, 10,11-dihydroxy-3,7,11-trimethyl-dodeca-2,6-dienyl ester298C17H30O4Ester41.650.08Insecticidal[51]
16Bis(2-ethylhexyl) phthalate390C24H38O4Phthalate ester44.350.35Antioxidant and
Anticancer		[52,53]
17Gamma-Sitosterol414C29H50OSteroid 55.660.05Anticancer[54]
Table
Table 3. Phenolic compounds identification of methanol extract of T. purpurea subsp. apollinea using HPLC.
Table 3. Phenolic compounds identification of methanol extract of T. purpurea subsp. apollinea using HPLC.
No.CompoundsMWM.F.CategoryRtmg/100 g DWtBiological
Activities		References
1Gallic acid170C7H6O5Phenolic acids3.381.24Antioxidant and Anticancer[55,56]
2Chlorogenic acid354 C16H18O9 Phenolic compound4.208.10Antioxidant and Anticancer[57]
4Methyl gallate184C8H8O5Gallate ester5.520.44Antioxidant and Anticancer[58]
5Coffeic acid180C9H8O4Polyphenol6.020.66Antioxidant and Anticancer[59]
7Pyrocatechol110C6H6O2Phenolic compounds6.700.36Antioxidant and Anticancer [60]
8Rutin610.5C27H30O16Flavonoid 7.730.76Antioxidant and Anticancer[61]
9Ellagic acid302C14H6O8Tannins8.960.06Antioxidant and Anticancer[62]
10Coumaric acid164C9H8O3Phenolic compound9.380.15Antioxidant and Anticancer[63]
11Vanillin152C8H8O3 Phenolic aldehyde10.050.45 Antioxidant and Anticancer[64]
12Ferulic acid194C10H10O4Phenolic acid10.360.14Antioxidant and Anticancer[65]
13Naringenin580.5C27H32O14Flavanones10.530.12Antioxidant and Anticancer[66]
14Daidzein254C15H10O4Isoflavone12.380.07Antioxidant and Anticancer[67]
15Quercetin302C15H10O7Flavonoid 12.756.76Antioxidant and Anticancer[68]
16Cinnamic acid148C9H8O2Monocarboxylic acid14.120.01Antioxidant and Anticancer[69]
17Apigenin270C15H10O5Flavones14.500.01Antioxidant and Anticancer[70]
18Kaempferol286C15H10O6Flavonol 15.002.29Antioxidant and Anticancer[71]
19Hesperetin302C16H14O6Flavanone15.590.06Antioxidant and Anticancer[72]
Table
Table 4. DPPH radical scavenging of T. purpurea subsp. apollinea extracts and ascorbic acid.
Table 4. DPPH radical scavenging of T. purpurea subsp. apollinea extracts and ascorbic acid.
DPPH Scavenging%
Conc. µg/mLT. purpurea subsp. apollinea Ascorbic Acid
100084.1 ± 0.3 ***a IC50 =
46.7 ± 0.7 *** μg/mL		97.1 ± 0.1a IC50 =
4.8 ± 0.1 μg/mL
50076.2 ± 0.1 ***94.5 ± 0.2
25069.3 ± 0.3 ***92.7 ± 0.2
12561.4 ± 0.1 ***86.4 ± 0.3
62.552.6 ± 0.1 ***77.9 ± 0.3
31.2546.0 ± 0.2 ***71.2 ± 0.2
15.62539.4 ± 0.2 ***64.2 ± 0.3
7.812529.8 ± 0.6 ***56.2 ± 0.2
3.921.2 ± 0.6 ***45.9 ± 0.1
1.9512.2 ± 0.2 ***41.8 ± 0.5
a IC50: The half-maximal inhibitory concentration. The findings are represented as mean ± standard deviation. *** p = 0.0001 show significant changes in comparison to ascorbic acid. The T. purpurea subsp. apollinea methanolic extract and ascorbic acid were compared using a t-test.
Table
Table 5. ABTS radical scavenging of T. purpurea subsp. apollinea extracts and trolox.
Table 5. ABTS radical scavenging of T. purpurea subsp. apollinea extracts and trolox.
ABTS Scavenging%
Conc. µg/mLT. purpurea subsp. apollinea Conc. µg/mLTrolox
15094.1 ± 0.2 **a IC50 =
46.7 ± 2.6 *** μg/mL		8.892.6 ± 0.2a IC50 =
2.9 ± 0.1 μg/mL
7572.4 ± 0.7 *6.283.6 ± 1.9
37.535.0 ± 3.7 ***3.849.6 ± 2.6
18.7515.1 ± 1.3 **1.318.6 ± 0.4
9.379.2 ± 0.1 ns0.69.9 ± 0.3
a IC50: The half-maximal inhibitory concentration. The findings are represented as mean ± standard deviation. ns p = 0.5; * p = 0.05; ** p = 0.01; *** p = 0.0001 show significant changes in comparison to trolox. The T. purpurea subsp. apollinea methanolic extract and trolox were compared using a t-test.
Table
Table 6. Anticancer effects of T. purpurea subsp. apollinea methanol extract on cancer and non-cancer cell lines.
Table 6. Anticancer effects of T. purpurea subsp. apollinea methanol extract on cancer and non-cancer cell lines.
a IC50 (µg/mL)
Cell LinesT. purpurea subsp. apollinea Extract95% Confidence Interval R2 ValueDoxorubicin
(Positive Control)
b MCF7 102.9 ± 0.5 ***93.8 to 113.5 0.937.4 ± 0.1
c MG63 118.3 ± 2.4 ***102.0 to 171.0 0.919.0 ± 0.3
d T47D114.7 ± 1.0 ***103.0 to 135.0 0.97.0 ± 0.1
e HeLa196.2 ± 2.3 ***171.1 to 211.2 0.941.9 ± 0.1
f PC3117.6 ± 1.0 ***104.0 to 165.4 0.946.3 ± 0.2
g U937248.4 ± 7.5 ***215.2 to 311.4 0.941.7 ± 0.9
h WI38242.9 ± 1.8 ***207.5 to 374.8 0.920.1 ± 0.1
a IC50: The half-maximal inhibitory concentration. b breast cancer (MCF7), c osteosarcoma (MG63), d breast ductal carcinoma (T47D), e cervical cancer (HeLa), f prostate cancer (PC3), g leukemia (U937) and h normal human fetal lung fibroblast (WI38). The findings are shown as mean ± standard deviation. *** p = 0.0001 show significant difference in comparison to doxorubicin. The T. purpurea subsp. apollinea and doxorubicin were compared using t-test analysis.
Table
Table 7. Selectivity indices of T. purpurea subsp. apollinea methanol extract for cancer cell lines.
Table 7. Selectivity indices of T. purpurea subsp. apollinea methanol extract for cancer cell lines.
a SI
Cell Linesb MCF7c MG63d T47De HeLaf PC3g U937
T. purpurea subsp. apollinea Extract 2.32.02.11.22.00.9
Doxorubicin0.51.02.80.40.40.4
a SI: Selectivity index, b breast cancer (MCF7), c osteosarcoma (MG63), d breast ductal carcinoma (T47D), e cervical cancer (HeLa), f prostate cancer (PC3), g leukemia (U937).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Youssef, A.M.M.; Maaty, D.A.M.; Al-Saraireh, Y.M. Phytochemical Analysis and Profiling of Antioxidants and Anticancer Compounds from Tephrosia purpurea (L.) subsp. apollinea Family Fabaceae. Molecules 2023, 28, 3939. https://doi.org/10.3390/molecules28093939

AMA Style

Youssef AMM, Maaty DAM, Al-Saraireh YM. Phytochemical Analysis and Profiling of Antioxidants and Anticancer Compounds from Tephrosia purpurea (L.) subsp. apollinea Family Fabaceae. Molecules. 2023; 28(9):3939. https://doi.org/10.3390/molecules28093939

Chicago/Turabian Style

Youssef, Ahmed M. M., Doaa A. M. Maaty, and Yousef M. Al-Saraireh. 2023. "Phytochemical Analysis and Profiling of Antioxidants and Anticancer Compounds from Tephrosia purpurea (L.) subsp. apollinea Family Fabaceae" Molecules 28, no. 9: 3939. https://doi.org/10.3390/molecules28093939

Article Metrics

Back to TopTop